Home/ Crypto News/ Spyre Therapeutics (SYRE) Stock Surges as Guggenheim Declares It Top Biotech Following UC Trial Results
blockonomi 1 week ago

Spyre Therapeutics (SYRE) Stock Surges as Guggenheim Declares It Top Biotech Following UC Trial Results

Stocks

Spyre Therapeutics (SYRE) stock climbs 2% after Guggenheim names it top biotech pick. SPY003 Phase II ulcerative colitis data shows promise. Analysis inside.

The post Spyre Therapeutics (SYRE) Stock Surges as Guggenheim Declares It Top Biotech Following UC Trial Results appeared first on Blockonomi.

Source: Source: Blockonomi

Related News

Trending Category

200-day moving average 24/7 trading 4-Year Cycle AAP Stock AB 2409 AI AI Agents AI Data Centers AI IPO market AI Infrastructure AI Stocks AI automation AI backlash AI capital rotation AI spending AI trading AMD Stock AML AML compliance AMM Liquidity Pools

Latest News

Exchange Here